PLoS ONE (Jan 2017)

Angiopoietin-like-4 and minimal change disease.

  • Gabriel Cara-Fuentes,
  • Alfons Segarra,
  • Cecilia Silva-Sanchez,
  • Heiman Wang,
  • Miguel A Lanaspa,
  • Richard J Johnson,
  • Eduardo H Garin

DOI
https://doi.org/10.1371/journal.pone.0176198
Journal volume & issue
Vol. 12, no. 4
p. e0176198

Abstract

Read online

BACKGROUND:Minimal Change Disease (MCD) is the most common type of nephrotic syndrome in children. Angiopoietin-like-4 (Angplt4) has been proposed as mediator of proteinuria in MCD. The aim of this study was to evaluate the role of Angptl4 as a biomarker in MCD. METHODS:Patients with biopsy-proven primary MCD, focal segmental glomerulosclerosis, membranous nephropathy (60, 52 and 52 respectively) and 18 control subjects had urinary and serum Angptl4 measured by Elisa. Frozen kidney tissue sections were stained for Angptl4. RESULTS:Angptl4 was not identified in glomeruli of MCD patients in relapse. Urinary Angptl4 levels were elevated in MCD in relapse as well as in patients with massive proteinuria due to other glomerular diseases. CONCLUSION:Neither serum nor urine Angptl4 appear to be good biomarkers in MCD. Elevated urinary Angptl4 n glomerular disease appears to reflect the degree of proteinuria rather than any specific disease.